TickerFacts.

Zura Bio Ltd (ZURA): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$49.0K
Year ended 2025-12-31
2024-12-31: $9.0K2025-12-31: $49.0K$49.0K
2024-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$49.0K+444.4%2026-03-19, From 2025-01-01
2024-12-31$9.0Kn/a2026-03-19, From 2024-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Zura Bio Ltd (ZURA)2025-12-31$49.0K+444.4%
Lineage Cell Therapeutics, Inc. (LCTX)2025-12-31$699.0K+19.1%
Artiva Biotherapeutics, Inc. (ARTV)2025-12-31$2.60M+6.8%
Surrozen, Inc. (SRZN)2025-12-31$537.0K-62.8%
Quince Therapeutics, Inc. (QNCX)2025-12-31$142.0K-23.7%
aTYR PHARMA INC (ATYR)2025-12-31$664.0K-6.2%
Inhibrx Biosciences, Inc. (INBX)2025-12-31$2.48M+8.7%
Tenaya Therapeutics, Inc. (TNYA)2025-12-31$8.44M-0.4%
ImageneBio, Inc. (IMA)2025-12-31$400.0K-63.6%

Compare ZURA, LCTX, ARTV, SRZN side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗